Seasonal affective Disorder (SAD) is a type of mood disorder. It causes symptoms mostly during a specific period of the year, typically during the fall and winter months when the days are shorter and darker. Though this ailment normally resolves after a few months, it can have a significant impact on how a person feels and operates.
Symptoms:
SAD symptoms develop on a continuous basis, with symptoms returning each winter. Symptoms may include:
- Depression
- Fatigue
- Social withdrawal
- Increased sleep
- Increased appetite and carbohydrate cravings
- Weight gain
- Irritability
- Interpersonal difficulties (especially rejection sensitivity)
- A heavy, leaden feeling in the arms or legs
Causes:
It is believed that seasonal affective disorder is due to an altercation in the body's normal circadian rhythm. This is influenced by the sunlight entering through the eyes.
Diagnosis:
- A depressed mood due to a medical condition, or related to the content of a delusion or hallucination which the person may be experiencing is not taken into consideration
- Depressed mood
- Loss of interest in activities that were once considered pleasurable
- Changes in either appetite or weight, without the intent of curtailing food intake for the purpose of gaining or losing weight
- Sleeping excessively or not enough
- Psychomotor agitation or retardation
- Fatigue or loss of energy
- Feelings of worthlessness or excessive/decessive guilt
- Problems concentrating, thinking, or making decisions
- Thoughts of death or suicide
Treatment:
Light Therapy:
- The initial "dose" for light therapy using a fluorescent light box is 10,000 lux for 30 minutes daily. Or, light boxes emitting 2,500 lux require two hours of exposure daily.
- To achieve optimum response to treatment, light therapy should be instituted early in the morning upon awakening.
- Response to light therapy may be seen within one week, though patients who do not respond may take up to four weeks.
- Common side effects of light therapy include headache, eyestrain, nausea, and agitation; however, these tend to be moderate, temporary, or resolve with lowered dosages of light.
Medications:
On June 12, 2006, Wellbutrin XL (bupropion hydrochloride) became the first drug approved specifically for SAD in the United States.
The efficacy of Wellbutrin XL in the prevention of SAD episodes was established in three double-blind, placebo-controlled trials in adult patients with a history of major depressive disorder in fall and winter.
Treatment started in the September to November period, well before the onset of symptoms. Treatment was discontinued the first week of spring.
In these studies, the percentage of patients who were depression-free at the end of treatment was significantly higher in Wellbutrin XL-treated patients than in placebo-treated patients.
The overall rate of patients depression-free at the end of treatment across the three studies was 84% for those on Wellbutrin XL and 72% for those on placebo.
Wellbutrin XL is chemically unrelated to the other common antidepressant medications, a class of drugs called SSRIs. As a matter of fact, there is no convincing evidence from randomized trials to support the use of SSRIs in treating SAD.
1 Comments
I read the above article and got some knowledge from your article which is about Anxiety Depression Treatment It's actually great and useful data for us. Thanks for sharing it.
ReplyDelete